NAD(P)H: quinone oxidoreductase 1 attenuates oxidative stress and apoptosis by regulating Sirt1 in diabetic nephropathy

Abstract

Background Diabetic nephropathy (DN) is one of the main complications of diabetes, and oxidative stress plays an important role in its progression. NAD(P)H: quinone oxidoreductase 1 (NQO1) protects cells from oxidative stress and toxic quinone damage. In the present study, we aimed to investigate the protective effects and underlying mechanisms of NQO1 on diabetes-induced renal tubular epithelial cell oxidative stress and apoptosis. Methods In vivo, the kidneys of db/db mice, which are a type 2 diabetes model, were infected with adeno-associated virus to induce NQO1 overexpression. In vitro, human renal tubular epithelial cells (HK-2 cells) were transfected with NQO1 pcDNA3.1(+) and cultured in high glucose (HG). Gene and protein expression was assessed by quantitative real-time PCR, western blotting, immunofluorescence analysis, and immunohistochemical staining. Reactive oxygen species (ROS) were examined by MitoSox red and flow cytometry. TUNEL assays were used to measure apoptosis. Result In vivo, NQO1 overexpression reduced the urinary albumin/creatinine ratio (UACR) and blood urea nitrogen (BUN) level in db/db mice. Our results revealed that NQO1 overexpression could significantly increase the ratio of NAD+/NADH and silencing information regulator 1 (Sirt1) expression and block tubular oxidative stress and apoptosis in diabetic kidneys. In vitro, NQO1 overexpression reduced the generation of ROS, NADPH oxidase 1 (Nox1) and Nox4, the Bax/Bcl-2 ratio and the expression of Cleaved Caspase-3 and increased NAD+/NADH levels and Sirt1 expression in HK-2 cells under HG conditions. However, these effects were reversed by the Sirt1 inhibitor EX527. Conclusions All these data suggest that NQO1 has a protective effect against oxidative stress and apoptosis in DN, which may be mediated by the regulation of Sirt1 through increasing intracellular NAD+/NADH levels. Therefore, NQO1 may be a new therapeutic target for DN.

Formononetin Attenuates Renal Tubular Injury and Mitochondrial Damage in Diabetic Nephropathy Partly via Regulating Sirt1/PGC-1α Pathway

“…Mammalian silent information regulator two homolog-1 (Sirt1) is an NAD + -dependent protein deacetylase, which has been proved to have renoprotective effects ( Morigi et al, 2018 ). Sirt1 has been reported to play beneficial roles in DN, such as anti-inflammatory and reducing oxidative stress ( Sun et al, 2021 ; Qiu et al, 2022 ). Peroxisome proliferator receptor-γ coactivator 1 (PGC-1α) is a significant downstream target of Sirt1.…”

Tenovin-1 Ameliorates Renal Fibrosis in High-Fat-Diet-Induced Diabetic Nephropathy via Antioxidant and Anti-Inflammatory Pathways

“…The IHC results of SIRT1 in our investigation, which demonstrate the distribution of SIRT1 in both glomerular and non-glomerular portions of healthy and sick rat kidney tissues, are comparable with the results of this study. Other findings also demonstrated the nuclear and cytoplasmic expression of Sirt1 in both glomerulus and tubular cells [ 95 ].…”

NRF2: A crucial regulator for mitochondrial metabolic shift and prostate cancer progression

“…Levels of NAD and NADPH regulate overall oxidative stress and metabolic shifts in PCa. Although NRF2 regulates NAD/NADPH ratio via NQO1 and total decrease in oxidative stress, NOX4 also can regulate the NAD/NADPH ratio independent of NRF2 (Papadimitriou et al, 2015;Mejia et al, 2018;Qiu et al, 2022). Therefore, glutathione oxidation and NOX4 activity needs to be considered during investigation on PCa metabolic shift, especially in the reduced NRF2 conditions, which have not carefully studied in the literature.…”